Thursday, January 11, 2024 — An updated immunisation plan for U.S. adults for 2024 is given in a clinical guideline that came out online on January 11 in the Annals of Internal Medicine.
Neil Murthy, M.D., M.P.H., from the U.S. Centres for Disease Control and Prevention in Atlanta, and his colleagues break down the Recommended Adult Immunisation Schedule for Ages 19 Years or Older, United States, 2024. They are writing this for the Advisory Committee on Immunisation Practices (ACIP).
The authors say that the adult immunisation schedule for 2024 has been changed to include new guidelines for the COVID-19 vaccine. These include the idea that all adults should get at least one dose of the updated vaccine. New to the adult immunisation schedule is the respiratory syncytial virus vaccine. Routine use of Abrysvo (Pfizer) is recommended during pregnancy (at 32 to 36 weeks of gestation); for adults aged 60 and up, shared clinical decision-making is recommended for vaccination with either Abrysvo (Pfizer) or Arexvy (GlaxoSmithKline).
“The CDC’s Advisory Committee on Immunisation Practices’ Recommended Adult Immunisation Schedule, United States, 2024 confirms ACIP’s competence in preparing current, evidence-based vaccination recommendations,” write Scott C. Ratzan, M.D., from the Graduate School of Public Health and Health Policy at the City University of New York in New York City, and others in an editorial that goes with the report. “However, it also demonstrates that CDC has not moved sufficiently beyond merely providing information to clinicians and the public to persuasive communication.”
Editorial (may need a membership or payment)
Disclaimer: Note that the statistical information in medical articles only shows broad trends and does not apply to specific people. Different things can make a big difference. When making decisions about your own health care, you should always get personalised medical advice.